ADHD drug effective for people with dependency

People with ADHD and substance dependence rarely respond as they should to ADHD medication. A randomised study from Karolinska Institutet now shows that it is possible to obtain the desired efficacy by administering the drug in higher doses. The results of the study are published in the scientific journal Addiction.

ADHD is much more common in people who use drugs than in the population at large. ADHD can be treated with , a CNS stimulant used for both children and adults. However, no previous studies have been able to show that methylphenidate is effective against ADHD in people with dependence. One possible reason for this lack of potency is that the doses tested were too low to have an effect on people with ADHD and long-standing , since such individuals have often developed a tolerance to CNS stimulants.

In this latest study, researchers examined the effect of the medication on prison inmates with ADHD and amphetamine dependenc, using doses up to double those administered in previous studies. What they found was that the experimental group had fewer relapses into drug use, displayed fewer ADHD symptoms and adhered to their treatment regimens for longer than the placebo group.

"We've shown for the first time that ADHD in these patients is treatable," says lead-author Dr Maija Konstenius at the Department of Clinical Neuroscience. "Moreover, the treatment led to fewer relapses to drug use, which is a very significant finding since a return to crime is often linked to drug abuse in this group."

The present study was a randomised placebo-controlled clinical trial involving 54 incarcerated men diagnosed with ADHD and with amphetamine dependence. The participants were randomly assigned to either of two groups, one that received methylphenidate (Concerta) and one that received an identical placebo (inactive pill) for a total of 24 weeks. The participants began their treatment two weeks before their release from prison and then continued it during non-custodial care. They also received psychological therapy to help them handle the risk of relapsing into use.

More information: Konstenius, M. et al. Methylphenidate for ADHD and Drug Relapse in Criminal Offenders with Substance Dependence: A 24-week Randomized Placebo-controlled Trial, Addiction, October 2013. DOI: 10.1111/add.12369

Related Stories

Added benefit of lisdexamfetamine is not proven

date Sep 03, 2013

Lisdexamfetamine dimesylate (trade name: Elvanse) has been approved in Germany since March 2013 as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (ADHD) in children aged 6 years and ...

Adult ADHD undertreated despite effective interventions

date Oct 07, 2013

Up to two-thirds of children with attention deficit/hyperactivity disorder (ADHD) find their disorder persists into adulthood yet only a small proportion of adults ever receive a formal diagnosis and treatment, research suggests.

Recommended for you

Smokers who use e-cigarettes less likely to quit

date Apr 16, 2015

The rapid increase in use of e-cigarettes has led to heated debates between opponents who question the safety of these devices and proponents who claim the battery-operated products are a useful cessation tool. A study, published ...

Evidence that synthetic drugs can cause cancer

date Apr 16, 2015

Almost weekly, a new synthetic psychoactive drug comes onto the market somewhere in Europe that can be ordered legally and easily, for example as an incense blend, via the Internet. Synthetic cannabinoids ...

Benefits of heroin treatment for drug users

date Apr 14, 2015

Drug users who do not benefit from conventional treatments for heroin addiction should be able to access the drug through the health system, urges a Canadian expert in The BMJ today.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.